Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Game-changer for prostate cancer? AstraZeneca’s Truqap shows remarkable results in pivotal trial
AstraZeneca has announced results from its CAPItello-281 Phase III trial, revealing that Truqap (capivasertib), when combined with abiraterone and androgen deprivation therapy (ADT), significantly improves ... Read More
Cassava Sciences stock craters after Alzheimer’s drug trial flops in critical phase
Cassava Sciences, Inc., a clinical-stage biotechnology company, revealed a significant setback in its pursuit of an effective treatment for Alzheimer’s disease. The company reported that ... Read More
Aurobindo Pharma USA announces strategic partnership for respiratory drugs
Aurobindo Pharma USA Inc., a wholly owned subsidiary of Aurobindo Pharma Limited, has secured a major collaboration and license agreement with an unnamed global pharmaceutical ... Read More
Hanmi Pharmaceutical, Beijing Hanmi progress cancer therapy BH3120 with promising trial results
Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical are making significant strides in the development of BH3120, a next-generation cancer immunotherapy. Updates on the innovative treatment were ... Read More
Zai Lab and Pfizer collaborate to address drug-resistant infections in China
Zai Lab and Pfizer have entered a partnership to commercialize XACDURO (sulbactam-durlobactam) in mainland China, addressing the rising threat of drug-resistant infections caused by carbapenem-resistant ... Read More
FDA accepts Bayer’s application to expand NUBEQA’s use in prostate cancer treatment
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s supplemental new drug application (sNDA) for NUBEQA (darolutamide), potentially broadening its use for patients with ... Read More
Could this startup have the cure for obesity? Meet Pep2Tango Therapeutics!
Versant Ventures has introduced Pep2Tango Therapeutics Inc., a biotechnology startup dedicated to pioneering next-generation therapies for weight loss. The company has secured significant, albeit undisclosed, ... Read More
Rallybio Phase 2 trial of RLYB212 begins to tackle FNAIT in high-risk pregnancies
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company known for advancing innovative therapies for rare diseases, has commenced its Phase 2 clinical trial for RLYB212. ... Read More
OncoVerity accelerates AML treatment with Series A extension
OncoVerity, a leader in integrating bioinformatics with oncology drug development, has closed a Series A extension financing round, bolstered by its key investors, argenx and ... Read More
Virpax Pharmaceuticals extends collaboration with NIH for pain management drug development
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company focused on innovative pharmaceutical solutions for pain management, announced the extension of its cooperative research and development agreement ... Read More